The DOI matches its Crossref record; 48 of the 49 references it cites were found in a registry or an index.
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency
Open accessAbstract
OBJECTIVES: Adult hypopituitarism with growth hormone deficiency (GHD) results in reduced exercise capacity, detrimental changes in body composition and lipid profiles and may be associated with an excess cardiovascular mortality. Endothelial dysfunction is an early event in the pathogenesis of atherosclerosis and predisposes to the deposition of unstable atherosclerotic plaques. We have used a noninvasive method to assess endothelial function in the brachial arteries of a group of treated hypopituitary adults with GHD, and a group of healthy age- and sex-matched controls. PATIENTS: Seventeen hypopituitary adults with GHD (13 male, 4 female) aged 26-54 years were studied. Each patient was receiving standard replacement therapy for all other hormonal deficiencies such that all target hormones were maintained in the normal reference range. All observations obtained were compared with those made in age- and sex-matched control subjects. All study subjects had no identifiable risk factors for endothelial dysfunction. MEASUREMENTS: Using an ultrasound vessel wall tracking system, the diameter of the left brachial artery was measured at rest, in response to reactive hyperaemia (endothelium-dependent dilation) and following sublingual glyceryl trinitrate (GTN) (endothelium-independent vasodilatation). We also measured fasting lipids, insulin, plasma glucose, glycated haemoglobin (HbA1c) and IGF-1, and studied the relationship of these parameters to endothelial function. RESULTS: Flow mediated endothelium-dependent dilatation (FMD), expressed as a percentage change from resting base-line diameter, was significantly impaired in the GHD group (3.70 +/- 2.36% vs. 7.30 +/- 2.42%, P < 0.001). In contrast, GTN-mediated dilatation was similar in both groups. There were no differences in total cholesterol, HDL cholesterol, LDL cholesterol or plasma triglyceride between the groups. Both fasting insulin (27.1 +/- 18.1 vs. 15.89 +/- 6.65 mU/l, P < 0.05) and glycated haemoglobin (HbA1c) levels (5.29 +/- 0.43 vs. 4.91 +/- 0.43%, P < 0.05) were significantly higher in the GHD group. FMD in both groups showed an inverse relationship with total cholesterol (r = -0.58, P < 0.05, GHD and r = -0.55, P < 0.05 controls). However, in the GHD subjects, there was a strong inverse relationship between FMD and LDL-cholesterol (r = -0.81, P < 0.0001). No other relationships were noted between FMD and any other metabolic parameters, or characteristics of GHD. CONCLUSIONS: Endothelial dysfunction is present in GH deficient adults prior to the onset of overt atherosclerotic disease. The similar glucose yet elevated fasting insulin levels imply a state of relative insulin insensitivity. The strong inverse correlation between endothelial dysfunction and LDL-cholesterol suggests a possible aetiological role for LDL-cholesterol in the pathogenesis of any excess cardiovascular risk associated with adult hypopituitarism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Altered body composition, insulin resistance, hypertension, unfavorable lipid profile, endothelial dysfunction and atherosclerosis have been found in several studies on patients with long-term GHD (74,76,77,(82)(83)(84)(85)(86)(87).”
From Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach (2015) · cites this paper as [82]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,618
Enzymatic determination of total serum cholesterol.
Allain, C. C., Poon, L. S., Chan, C. S. G., Richmond, W., & Fu, P. C. (1974) · Clinical Chemistry · doi:10.1093/clinchem/20.4.470 · Cited by 9,845
Epstein, F. H., Steinberg, D. I., Parthasarathy, S., Carew, T. E., Khoo, J. C., & Witztum, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201407 · Cited by 6,425
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,885
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742
Book ReviewAmbulatory Pediatric Care
Steinberg, J. B. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901053200122 · Cited by 2,105
Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction
Austin, M. A. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03410130125037 · Cited by 1,780
Atherosclerosis: Basic Mechanisms
Berliner, J. A., Navab, M., Fogelman, A. M., Frank, J. S., Demer, L. L., Edwards, P. A., Watson, A. D., & Lusis, A. J. (1995) · Circulation · doi:10.1161/01.cir.91.9.2488 · Cited by 1,730
Joannidès, R., Haefeli, W. E., Linder, L., Richard, V. J., Bakkali, E. H., Thuillez, C., & Lüscher, T. F. (1995) · Circulation · doi:10.1161/01.cir.91.5.1314 · Cited by 1,622
Research works printed but not linked: 7
- 10.1210/jc.81.3.1169 · DOI · Paper page
- Bellamy M., 1996, Hyperhomocysteinaemia and endothelial dysfunction with low Vitamin B12/folate status, Circulation, 94, 1
- Bones C., 1997, Endothelial function in healthy young adults is rapidly improved by physical training, European Heart Journal, 18, 265
- Goodfellow J. Ramsey M. Bellamy M. Gorman S. Brownlee M. Lewis M.(1998)Effect of dietary omega‐3 fatty acids (fish oils) supplements on endothelial dysfunction in hypercholesterolaemic subjects.European Heart Journal in press.
- 10.1210/jc.81.7.2448 · DOI
- 10.1210/en.136.9.3767 · DOI
- Rosen T., 1994, Beneficial effects of 12 months replacement with recombinant human GH to GHD adults, Endocrinology and Metabolism, 1, 55
Cited by
Sorted by citations
Association between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
Colao, A., Marzullo, P., Somma, C. D., & Lombardi, G. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01218.x · Cited by 386
Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257
Bots, M. L., Westerink, J., Rabelink, T. J., & de Koning, E. J. P. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi017 · Cited by 240
Pituitary Dysfunction After Traumatic Brain Injury: A Clinical and Pathophysiological Approach
Tanriverdi, F., Schneider, H. J., Aimaretti, G., Masel, B. E., Casanueva, F. F., & Kelestimur, F. (2015) · Endocrine Reviews · doi:10.1210/er.2014-1065 · Cited by 218
The GH–IGF‐I axis and the cardiovascular system: clinical implications
Colao, A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03292.x · Cited by 210
Bailey‐Downs, L. C., Mitschelen, M. C., Sosnowska, D., Tóth, P., Pinto, J. T., Ballabh, P., Valcarcel‐Ares, M. N., Farley, J. A., Koller, Á., Henthorn, J., et al. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr164 · Cited by 169
The Emerging Role of IGF-1 Deficiency in Cardiovascular Aging: Recent Advances
Ungvari, Z. I., & Csiszár, A. (2012) · The Journals of Gerontology Series A · doi:10.1093/gerona/gls072 · Cited by 158
Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice
Csiszár, A., Labinskyy, N., Pérez, V., Recchia, F. A., Podlutsky, A. J., Mukhopadhyay, P., Losonczy, G., Pacher, P., Austad, S. N., Bartke, A., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.412.2008 · Cited by 148
Smith, J. C., Evans, M., Wilkinson, I. B., Goodfellow, J., Cockcroft, J., Scanlon, M. F., & Davies, J. S. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01514.x · Cited by 132
Self-citationOverall and cause-specific mortality in GH-deficient adults on GH replacement
Gaillard, R. C., Mattsson, A. F., Åkerblad, A., Bengtsson, B., Cara, J. F., Feldt‐Rasmussen, U., Kołtowska‐Häggström, M., Monson, J. P., Saller, B., Wilton, P., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1028 · Cited by 130
Early Vascular Alterations in Acromegaly
Brevetti, G., Marzullo, P., Silvestro, A., Pivonello, R., Oliva, G., Somma, C. D., Lombardi, G., & Colao, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3174 · Cited by 107
Nuver, J., Smit, A. J., Postma, A., Sleijfer, D. T., & Gietema, J. A. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00038-5 · Cited by 105
Growth hormone replacement therapy for adults: Into the new millennium
Simpson, H., Savine, R., Sönksen, P. H., Bengtsson, B., Carlsson, L. M. S., Christiansen, J. S., Clemmons, D. R., Hintz, P. C. R., Ho, K. K. Y., Mullis, P. E., et al. (2002) · Growth Hormone & IGF Research · doi:10.1054/ghir.2001.0263 · Cited by 101
Risk Factors for Cerebrovascular Deaths in Patients Operated and Irradiated for Pituitary Tumors
Erfurth, E. M., Bülow, B., Svahn‐Tapper, G., Norrving, B. G., Odh, K., Mikoczy, Z., Björk, J., & Hagmar, L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020526 · Cited by 100
Beauregard, C., Utz, A. L., Schaub, A. E., Nachtigall, L., Biller, B. M. K., Miller, K. K., & Klibanski, A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2371 · Cited by 99
Inflammatory cardiovascular risk markers in women with hypopituitarism
Sesmilo, G., Miller, K. K., Hayden, D., & Klibanski, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8087 · Cited by 97
Elhadd, T. A., Abdu, T. A. M., Oxtoby, J., Kennedy, G., McLaren, M., Neary, R. H., Belch, J. J. F., & Clayton, R. N. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7813 · Cited by 88
Pharmacological Strategies to Retard Cardiovascular Aging
Alfaras, I., Germanio, C. D., Bernier, M., Csiszár, A., Ungvari, Z. I., Lakatta, E. G., & de Cabo, R. (2016) · Circulation Research · doi:10.1161/circresaha.116.307475 · Cited by 87
Beginning to end: Cardiovascular implications of growth hormone (GH) deficiency and GH therapy
Colao, A., Somma, C. D., Savanelli, M. C., Leo, M. D., & Lombardi, G. (2006) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2006.03.006 · Cited by 82
Abnormal Vascular Reactivity in Growth Hormone Deficiency
Capaldo, B., Guardasole, V., Pardo, F., Matarazzo, M., Rella, F. D., Numis, F. G., Merola, B., Longobardi, S., & Saccà, L. (2001) · Circulation · doi:10.1161/01.cir.103.4.520 · Cited by 79
Growth hormone deficiency and vascular risk
McCallum, R. W., Petrie, J. R., Dominiczak, A. F., & Connell, J. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01559.x · Cited by 80
Maison, P., Démolis, P., Young, J., SCHAISON, G., Giudicelli, J., & Chanson, P. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01127.x · Cited by 78
Adults with Partial Growth Hormone Deficiency Have an Adverse Body Composition
Murray, R. D., Adams, J. E., & Shalet, S. M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030761 · Cited by 77
Csiszár, A., Ungvari, A., Patai, R., Gulej, R., Yabluchanskiy, A., Benyó, Z., Kovács, I., Sótonyi, P., Kirkpartrick, A. C., Prodan, C. I., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01139-7 · Cited by 75
Bailey‐Downs, L. C., Sosnowska, D., Tóth, P., Mitschelen, M. C., Gautam, T., Henthorn, J., Ballabh, P., Koller, Á., Farley, J. A., Sonntag, W. E., et al. (2011) · The Journals of Gerontology Series A · doi:10.1093/gerona/glr197 · Cited by 69
Endothelial dysfunction in endocrine disease
Abdu, T. A. M. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00425-8 · Cited by 64
Colao, A., Somma, C. D., Rota, F., Pivonello, R., Savanelli, M. C., Spiezia, S., & Lombardi, G. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2247 · Cited by 62
Growth Hormone and the Cardiovascular System
Palmeiro, C., Anand, R. G., Dardi, I. K., Balasubramaniyam, N., Schwarcz, M., & Weiss, I. A. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e318248a3e1 · Cited by 57
Utz, A. L., Yamamoto, A., Hemphill, L., & Miller, K. K. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0169 · Cited by 56
Sesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7387 · Cited by 55
Murray, R. D., Wieringa, G., Lissett, C. A., Darzy, K. H., Smethurst, L., & Shalet, S. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01508.x · Cited by 54
Marzullo, P., Marcassa, C., Campini, R., Eleuteri, E., Minocci, A., Priano, L., Temporelli, P. L., Sartório, A., Vettor, R., Liuzzi, A., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0829 · Cited by 52
Colao, A., Somma, C. D., Filippella, M., Rota, F., Pivonello, R., Orio, F., Vitale, G., & Lombardi, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02105.x · Cited by 49
Vasoprotective Effects of Life Span-Extending Peripubertal GH Replacement in Lewis Dwarf Rats
Ungvari, Z. I., Gautam, T., Koncz, P., Henthorn, J., Pinto, J. T., Ballabh, P., Yan, H., Mitschelen, M. C., Farley, J. A., Sonntag, W. E., et al. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq147 · Cited by 46
Heffernan, K. S., Fahs, C. A., Ranadive, S. M., & Patvardhan, E. A. (2010) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248409354599 · Cited by 46
Makimura, H., Stanley, T. L., Mun, D., Chen, C. S., Wei, J., Connelly, J. M., Hemphill, L., & Grinspoon, S. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1295 · Cited by 42
Cardiovascular alterations in adult GH deficiency
Somma, C. D., Scarano, E., Savastano, S., Savanelli, M. C., Pivonello, R., & Colao, A. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.005 · Cited by 41
Characteristics of cardiac and vascular structure and function in Prader–Willi syndrome
Patel, S. A., Harmer, J. A., Loughnan, G., Skilton, M. R., Steinbeck, K. S., & Celermajer, D. S. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02808.x · Cited by 41
Cardiac Abnormalities in Acromegaly
Vitale, G., Pivonello, R., Lombardi, G., & Colao, A. A. L. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403050-00004 · Cited by 39
Metabolic Syndrome in Hypopituitarism
Miljić, D., & POPOVIC, V. M. (2018) · Frontiers of hormone research · doi:10.1159/000485997 · Cited by 38
Insulin sensitivity is impaired in adults with varying degrees of GH deficiency
Murray, R. D., & Shalet, S. M. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02194.x · Cited by 37
Peker, Y., Svensson, J., Hedner, J. A., Grote, L., & Johannsson, G. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02555.x · Cited by 36
Egecioglu, E., Andersson, I. J., Bollano, E., Pálsdóttir, V., Gabrielsson, B. G., Kopchick, J. J., Skøtt, O., Bie, P., Isgaard, J., Bohlooly‐Y, M., et al. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00335.2006 · Cited by 36
Metabolic alterations in patients who develop traumatic brain injury (TBI)-induced hypopituitarism
Prodam, F., Gasco, V., Caputo, M., Zavattaro, M., Pagano, L., Marzullo, P., Belcastro, S., Busti, A., Perino, C., Grottoli, S., et al. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.04.001 · Cited by 35
Abdu, T. A. M., Elhadd, T. A., Buch, H., Barton, D. M., Neary, R. H., & Clayton, R. N. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02109.x · Cited by 34
Cordido, F., García‐Buela, J., Sangiao‐Alvarellos, S., Martínez, T., & Vidal, O. (2010) · Mediators of Inflammation · doi:10.1155/2010/434562 · Cited by 33
Sverrisdóttir, Y. B., Elam, M., Caidahl, K., Söderling, A., Herlitz, H., & Johannsson, G. (2003) · PubMed · doi:10.1097/01.hjh.0000084757.37215.55 · Cited by 33
Mohn, A., Marzio, D. D., Giannini, C., Capanna, R., Marcovecchio, M. L., & Chiarelli, F. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02378.x · Cited by 33
Castillo, C., Ariznavarreta, M. C. C., Lahera, V., Cachofeiro, V., Gil-Loyzaga, P. E., & Tresguerres, J. A. F. (2005) · Biogerontology · doi:10.1007/s10522-004-7383-x · Cited by 34
Twickler, T., Dallinga-Thie, G., Visseren, F., de Vries, W. D., Erkelens, D., & Koppeschaar, H. (2003) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2002-020470 · Cited by 33
Barros, P. R., Costa, T. J. D., Akamine, E. H., & Tostes, R. C. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.727604 · Cited by 33
Protective actions of melatonin and growth hormone on the aged cardiovascular system
Paredes, S. D., Forman, K., Garcı́a, C., Vara, E., Escames, G., & Tresguerres, J. A. F. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0016 · Cited by 31
Devin, J. K., Blevins, L. S., Verity, D. K., Chen, Q., Bloodworth, J. R., Covington, J. W., & Vaughan, D. E. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0609 · Cited by 30
Paisley, A. N., Izzard, A. S., Gemmell, I., Cruickshank, K. J., Trainer, P. J., & Heagerty, A. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0948 · Cited by 29
Sverrisdóttir, Y. B., Elam, M., Caidahl, K., derling, A.-S. S., Herlitz, H., & Johannsson, G. (2003) · Journal of Hypertension · doi:10.1097/00004872-200310000-00018 · Cited by 34
Recovery of growth hormone secretion following cabergoline treatment of macroprolactinomas
George, L., Nicolau, N., Scanlon, M., & Davies, J. S. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01137.x · Cited by 28
Ariznavarreta, C., Castillo, C., Segovia, G., Mora, F., Azcoitia, Í., & Tresguerres, J. A. F. (2003) · HOMO · doi:10.1078/0018-442x-00065 · Cited by 27
Bhat, M. A., Laway, B. A., Shah, Z. A., Wani, A. I., & Mubarik, I. (2014) · Pituitary · doi:10.1007/s11102-014-0575-8 · Cited by 26
Twickler, T., Cramer, M., Dallinga-Thie, G., Chapman, M., Erkelens, D., & Koppeschaar, H. (2003) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2003-030278 · Cited by 30
Randeva, H. S., Lewandowski, K. C., Komorowski, J., Murray, R. D., O’Callaghan, C. J., Hillhouse, E. W., Stepien, H., & Shalet, S. M. (2004) · Circulation · doi:10.1161/01.cir.0000129763.51060.77 · Cited by 26
Smith, J. C., Lang, D., McEneny, J., Evans, M., Scanlon, M. F., Young, I. S., & Davies, J. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01493.x · Cited by 26
Self-citationDIAGNOSIS AND MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS
Stavrou, S., & Kleinberg, D. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70201-2 · Cited by 26
About the role of shear stress in atherogenesis
Bakker, S. J. L. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00392-2 · Cited by 26
Murray, R. D., Wieringa, G., Lawrance, J. A., Adams, J. E., & Shalet, S. M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03754.x · Cited by 24
Soares, D. V., Spina, L. D. C., Brasil, R. R. L. O., da Silva, E. M. C., Lobo, P. M., Salles, E. F., Coeli, C. M., Conceição, F. L., & Vaisman, M. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.011 · Cited by 24
Castillo, C., Cruzado, M., Ariznavarreta, C., Gil-Loyzaga, P. E., Lahera, V., Cachofeiro, V., & Tresguerres, J. A. F. (2005) · Biogerontology · doi:10.1007/s10522-005-4805-3 · Cited by 25
Serri, O., Li, L., Maingrette, F., Jaffry, N., & Renier, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030911 · Cited by 24
Hana, V, Prazny, M., Marek, J., Skrha, J., & Justova, V (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1470333 · Cited by 23
Graham, M. R. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3220 · Cited by 21
Body composition and vascular effects of growth hormone administration in old female rats
Castillo, C. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(03)00156-6 · Cited by 21
Growth hormone therapy influences endothelial function in children with renal failure
Liliën, M. R., Schr�der, C. H., Levtchenko, E. N., & Koomans, H. A. (2004) · Pediatric Nephrology · doi:10.1007/s00467-004-1495-z · Cited by 21
Cardiac evaluation in children with Prader–Willi syndrome
Marcus, K. A., der Velden, J. A.-V., Otten, B. J., Weijers, G., Yntema, H. G., de Korte, C. L., & Kapusta, L. (2011) · Acta Paediatrica · doi:10.1111/j.1651-2227.2011.02570.x · Cited by 20
Lanes, R., Marcano, H., Villaroel, O., Günczler, P., Morillo, E., Paoli, M., Perez, M. R., Maulino, N., & Palacios, A. (2008) · Hormone Research in Paediatrics · doi:10.1159/000151595 · Cited by 18
Krzyżanowska, K., Mittermayer, F., Schnack, C., Hofer, M., Wolzt, M., & Schernthaner, G.-H. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01474.x · Cited by 19
Growth Hormone Therapy in Adults
Conceição, F. L., Bojensen, A., Jørgensen, J. O. L., & Christiansen, J. S. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0215 · Cited by 18
Effects of GH on the Aging Process in Several Organs: Mechanisms of Action
Tresguerres, J. A. F., Tresguerres, I. F., Viña, J., Rancán, L., Paredes, S. D., Linillos-Pradillo, B., & Vara, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147848 · Cited by 22
van der Klaauw, A. A., Pereira, A. M., Rabelink, T. J., Corssmit, E. P. M., van Zonneveld, A. J., Pijl, H., de Boer, H. C., Smit, J. W. A., Romijn, J. A., & de Koning, E. J. P. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0179 · Cited by 18
Hypopituitarism and atherosclerosis
Elbadd, T. A., Abdu, T. A. M., & Clayton, R. N. (2001) · Annals of Medicine · doi:10.3109/07853890109002097 · Cited by 18
Growth Hormone Therapy for Adults: Not Ready for Prime Time?
Isley, W. L. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00011 · Cited by 18
Miljić, D., Miljić, P., Doknić, M., Pekić, S., Stojanović, M., Cvijović, G., Micić, D., & POPOVIC, V. M. (2013) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2013.08.005 · Cited by 17
Castillo, C., Salazar, V., Ariznavarreta, C., Vara, E., & Tresguerres, J. A. F. (2004) · Endocrine · doi:10.1385/endo:25:1:33 · Cited by 19
Growth hormone and cardiovascular risk markers
Klibanski, A. (2003) · Growth Hormone & IGF Research · doi:10.1016/s1096-6374(03)00065-0 · Cited by 17
Serum lipid and leptin concentrations in patients with Sheehan syndrome
Laway, B., Mir, S. A., Shah, T. A., Singh, H., & Shabir, I. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_23_18 · Cited by 16
Groban, L., Lin, M., Kassik, K. A., Ingram, R. L., & Sonntag, W. E. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.01.003 · Cited by 16
Echocardiographic assessment of cardiac morphology and function in mutant dwarf rats
Longobardi, S., Cittadini, A., Strömer, H., Katz, S. E., Grossman, J. D., CLARK, R. G., Morgan, J. P., & Douglas, P. S. (2000) · Growth Hormone & IGF Research · doi:10.1054/ghir.2000.0160 · Cited by 16
Graham, M. R., Evans, P., Thomas, N. E., Davies, B., & Baker, J. S. (2009) · American Journal of Cardiovascular Drugs · doi:10.2165/11312100-000000000-00000 · Cited by 15
Abdu, T. A. M., Elhadd, T. A., Akber, M., Hartland, A. J., Neary, R. H., & Clayton, R. N. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01364.x · Cited by 15
Subtle Cardiovascular Abnormalities in Prader-Willi Syndrome Might Begin in Young Adulthood
Kobayashi, S., Murakami, N., Oto, Y., Toide, H., Kimura, N., Hayashi, A., Higashi, A., Inami, S., Tanaka, J., Koshikawa, Y., et al. (2021) · Internal Medicine · doi:10.2169/internalmedicine.7073-21 · Cited by 15
Cardiovascular Effects of Growth Hormone Treatment: Potential Risks and Benefits
Colao, A. (2004) · Hormone Research in Paediatrics · doi:10.1159/000080498 · Cited by 14
SCOTT, E. M., Greenwood, J. P., Stoker, J. B., Mary, D., & Gilbey, S. G. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01546.x · Cited by 13
Nyström, H. C., Klintland, N., Caidahl, K., Bergström, G. M. L., & Wickman, A. (2005) · BMC Physiology · doi:10.1186/1472-6793-5-17 · Cited by 11
Castillo, C., Salazar, V., Ariznavarreta, C., Vara, E., & Tresguerres, J. A. F. (2005) · Endocrine · doi:10.1385/endo:26:1:011 · Cited by 10
Smith, J. C., Lane, H. A., Lewis, J., Dann, S., Goodfellow, J., Collins, P. W., Evans, M., Scanlon, M. F., & Davies, J. S. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021618 · Cited by 11
Self-citationYoung Little Mice Express a Premature Cardiovascular Aging Phenotype
Reddy, A. K., Hartley, C. J., Pham, T. T. T., Darlington, G., Entman, M. L., & Taffet, G. E. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt055 · Cited by 11
Nyúl‐Tóth, Á., Shanmugarama, S., Patai, R., Gulej, R., Faakye, J., Nagy, D., Nagykaldi, M., Kiss, T., Csípő, T., Milan, M., et al. (2025) · GeroScience · doi:10.1007/s11357-025-01653-2 · Cited by 10
Christ, E., Cummings, M. H., Stolinski, M., Jackson, N., Lumb, P. J., Wierzbicki, A. S., Sönksen, P. H., Russell-Jones, D. L., & Umpleby, A. M. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02105 · Cited by 10
Florido, M. H. C., & Ziats, N. P. (2024) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.37669 · Cited by 9
Ambulatory monitoring of blood pressure in growth hormone-deficient adults
Conceição, F. L., Mansur, V. A., Brasil, R. R. L. O., & Vaisman, M. (2002) · Blood Pressure Monitoring · doi:10.1097/00126097-200204000-00001 · Cited by 9
Ebrahimi, F., Andereggen, L., & Christ, E. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09888-8 · Cited by 8
Metadata
- Authors
- Evans, M., Davies, Goodfellow, Rees, & Scanlon
- Affiliations
- University Hospital of Wales (GB)
- Corresponding author
- M Evans
- ORCID
- M Evans
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 1999-04
- Volume
- 50
- Issue
- 4
- Pages
- 457-464
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1940926892
- Cited by
- 129
- References
- 49
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2 · 2019: 2 · 2018: 3 · 2017: 1 · 2016: 1 · 2015: 1 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- endothelial dysfunction, adult growth hormone deficiency, hypopituitarism, flow-mediated dilation, brachial artery, reactive hyperemia, nitroglycerin, insulin resistance, HbA1c, total cholesterol, insulin-like growth factor I, cardiovascular risk, atherosclerosis, hormone replacement therapy, lipid profile, endothelium-dependent vasodilatation, endothelium-independent vasodilatation
- MeSH terms
- Adult, Blood Glucose, Brachial Artery, Cardiovascular Diseases, Endothelium, Vascular, Female, Nitroglycerin, Humans, Hypopituitarism, Insulin, Cholesterol, LDL, Male, Middle Aged, Risk Factors, Growth Hormone, Ultrasonography, Vasodilation, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review